Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors

Safety data on MET inhibitors in patients with advanced NSCLC harboring MET exon 14 mutation and treated with frontline immune checkpoint inhibitors (ICIs) are still limited. Here, we describe clinical characteristics, liver biopsy features, and management of liver injury of two patients with a diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisi, Monia, Vitale, Giovanni, Fusaroli, Michele, Riefolo, Mattia, Giunchi, Valentina, D’Errico, Antonietta, Ardizzoni, Andrea, Raschi, Emanuel, Gelsomino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511802/
https://www.ncbi.nlm.nih.gov/pubmed/37745898
http://dx.doi.org/10.1016/j.jtocrr.2023.100563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511802/
https://www.ncbi.nlm.nih.gov/pubmed/37745898
http://dx.doi.org/10.1016/j.jtocrr.2023.100563

Ejemplares similares